Programmed death ligand-1 and CD8 tumor-infiltrating lymphocytes (TILs) as prognostic predictors in ovarian high-grade serous carcinoma (HGSC)

[1] Rosso M(2017)E-cadherin: a determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness. Castresana JS, editor PLoS One 12 e0184439-681

[2] Majem B(2006)Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma J Mol Med 84 671-9555

[3] Devis L(2013)Targeting signaling pathways in epithelial ovarian cancer Int J Mol Sci 14 9536-2530

[4] Lapyckyj L(2010)Expression and localization of e-cadherin in epithelial ovarian cancer Anticancer Res 30 2525-1374

[5] Besso MJ(2013)PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction Clin Cancer Res 19 1363-5039

[6] Llauradó M(2018)Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion Front Oncol 8 386-1011

[7] Lassus H(2016)PD-L1 expression in human cancers and its association with clinical outcomes Onco Targets Ther 9 5023-14

[8] Sihto H(2016)Prognostic significance of PD-L1 in patients with non–small cell lung cancer: a large cohort study of surgically resected cases J Thorac Oncol 11 1003-2902

[9] Leminen A(2017)Prognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancer Int Immunopharmacol 52 7-820

[10] Joensuu H(2009)Intraepithelial T cells and tumor proliferation Cancer 115 2891-250

[1] Rosso M(2017)E-cadherin: a determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness. Castresana JS, editor PLoS One 12 e0184439-681

[2] Majem B(2006)Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma J Mol Med 84 671-9555

[3] Devis L(2013)Targeting signaling pathways in epithelial ovarian cancer Int J Mol Sci 14 9536-2530

[4] Lapyckyj L(2010)Expression and localization of e-cadherin in epithelial ovarian cancer Anticancer Res 30 2525-1374

[5] Besso MJ(2013)PD-L1 on tumor cells is induced in ascites and promotes peritoneal dissemination of ovarian cancer through CTL dysfunction Clin Cancer Res 19 1363-5039

[6] Llauradó M(2018)Tumor-intrinsic PD-L1 signaling in cancer initiation, development and treatment: beyond immune evasion Front Oncol 8 386-1011

[7] Lassus H(2016)PD-L1 expression in human cancers and its association with clinical outcomes Onco Targets Ther 9 5023-14

[8] Sihto H(2016)Prognostic significance of PD-L1 in patients with non–small cell lung cancer: a large cohort study of surgically resected cases J Thorac Oncol 11 1003-2902

[9] Leminen A(2017)Prognostic value of tumor PD-L1 expression combined with CD8+ tumor infiltrating lymphocytes in high grade serous ovarian cancer Int Immunopharmacol 52 7-820

[10] Joensuu H(2009)Intraepithelial T cells and tumor proliferation Cancer 115 2891-250